ALT FY 2007 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena

ALTAltimmune, Inc.

$318M

FY 2007 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$15M+692.5% YoY

Gross Profit

$15M100.0% margin

Operating Income

-$17M-112.7% margin

Net Income

-$14M-92.8% margin

EPS (Diluted)

$-431.69

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$15M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$67M

Total Liabilities

$26M

Stockholders' Equity

$41M

Cash & Equivalents

$41M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$2M	+692.5%
Gross Profit	$15M	$2M	+692.5%
Operating Income	-$17M	$1M	-1471.5%
Net Income	-$14M	$1M	-1436.9%